COLL vs SO
Collegium Pharmaceutical Inc (COLL) versus Southern Company (SO) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Southern Company (SO) is a utilities - regulated electric company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported SO revenue for 2016-09-30 was $6.26B. Net income was $1.17B. Revenue was down 25.9% from 2016-06-30 to 2016-09-30. SO currently screens at market cap $101.55B and trailing P/E 22.1.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. SO currently screens at market cap $101.55B and trailing P/E 22.1.
Not investment advice. Open the COLL and SO stock pages for the full models.
Not investment advice.